4//SEC Filing
Benecchi Christopher 4
Accession 0001562180-25-001202
CIK 0001597553other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:27 PM ET
Size
7.0 KB
Accession
0001562180-25-001202
Insider Transaction Report
Form 4
Benecchi Christopher
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2025-02-13$7.18/sh−822$5,902→ 43,915 total
Footnotes (1)
- [F1]On February 13, 2025, the reporting person vested 3,375 shares of time-based restricted stock units (RSUs) granted on February 13, 2024 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vests 25% on each grant anniversary date over four years. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001881403
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:27 PM ET
- Size
- 7.0 KB